GENI (GENI) shareholder files Rule 144 notice to sell 91,724 shares

Rhea-AI Filing Summary

A holder of GENI common stock has filed a Rule 144 notice to sell 91,724 shares. The proposed sale is through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value listed as 995,132.02. The filing shows 214,097,454 common shares outstanding for the issuer.

The 91,724 shares to be sold were acquired on 01/05/2026 via restricted stock vesting from the issuer as compensation, with payment also dated 01/05/2026. The notice also reports that Mark Locke sold 131,608 common shares on 11/10/2025 for gross proceeds of 1,368,736.36 during the prior three months.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	91724	995132.02	214097454	01/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/05/2026	Restricted Stock Vesting	Issuer			91724	01/05/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark Locke 1st Floor 27 Soho Square London X0 W1D 3QR	Common	11/10/2025	131608	1368736.36

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many GENI shares are proposed to be sold under this Rule 144 notice?

The notice covers a proposed sale of 91,724 shares of GENI common stock.

What is the aggregate market value of the GENI shares to be sold?

The filing lists an aggregate market value of 995,132.02 for the 91,724 common shares to be sold.

When and how were the GENI shares being sold acquired?

The 91,724 common shares were acquired on 01/05/2026 through restricted stock vesting from the issuer as compensation, with the payment date also recorded as 01/05/2026.

Which broker and exchange are used for the planned GENI share sale?

The proposed transaction will use Fidelity Brokerage Services LLC as broker, and the common shares are listed for sale on the NYSE.

How many GENI shares are shown as outstanding in this notice?

The Rule 144 notice lists 214,097,454 common shares of the issuer as outstanding.

What GENI share sales in the last three months are disclosed in this filing?

The filing reports that Mark Locke sold 131,608 common shares on 11/10/2025, generating gross proceeds of 1,368,736.36.

What is the main purpose of this Form 144 related to GENI?

The Form 144 serves as a notice of the holder’s intention to sell 91,724 restricted or control shares of GENI common stock in reliance on Rule 144.